Terri A. Morrical Sells 7,600 Shares of Neogen Co. (NEOG) Stock

Neogen Co. (NASDAQ:NEOG) VP Terri A. Morrical sold 7,600 shares of the firm’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $61.69, for a total transaction of $468,844.00. Following the completion of the transaction, the vice president now owns 45,175 shares in the company, valued at $2,786,845.75. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Shares of NASDAQ:NEOG opened at $61.25 on Friday. The stock has a market capitalization of $3.17 billion, a P/E ratio of 50.62, a PEG ratio of 5.40 and a beta of 1.33. Neogen Co. has a fifty-two week low of $50.60 and a fifty-two week high of $97.38.

Neogen (NASDAQ:NEOG) last issued its quarterly earnings data on Tuesday, March 26th. The company reported $0.25 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.27 by ($0.02). The firm had revenue of $97.70 million during the quarter, compared to the consensus estimate of $102.55 million. Neogen had a net margin of 14.96% and a return on equity of 10.48%. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.32 earnings per share. On average, equities analysts predict that Neogen Co. will post 1.14 earnings per share for the current year.

NEOG has been the topic of a number of recent research reports. BidaskClub upgraded shares of Neogen from a “strong sell” rating to a “sell” rating in a research report on Wednesday, March 20th. ValuEngine downgraded shares of Neogen from a “buy” rating to a “hold” rating in a research report on Thursday, January 10th. Craig Hallum upgraded shares of Neogen from a “hold” rating to a “buy” rating and set a $62.76 price target on the stock in a research report on Tuesday, March 19th. Finally, Zacks Investment Research downgraded shares of Neogen from a “hold” rating to a “sell” rating in a research report on Tuesday, April 16th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $62.76.

Large investors have recently modified their holdings of the stock. Brand Asset Management Group Inc. bought a new stake in Neogen in the 1st quarter valued at about $39,000. First Hawaiian Bank bought a new stake in Neogen in the 4th quarter valued at about $26,000. Manchester Capital Management LLC lifted its position in Neogen by 105.6% in the 1st quarter. Manchester Capital Management LLC now owns 590 shares of the company’s stock valued at $34,000 after purchasing an additional 303 shares during the last quarter. Buffington Mohr McNeal bought a new stake in Neogen in the 1st quarter valued at about $43,000. Finally, Captrust Financial Advisors lifted its position in Neogen by 47.0% in the 4th quarter. Captrust Financial Advisors now owns 970 shares of the company’s stock valued at $55,000 after purchasing an additional 310 shares during the last quarter. Hedge funds and other institutional investors own 88.98% of the company’s stock.

WARNING: This report was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/05/10/terri-a-morrical-sells-7600-shares-of-neogen-co-neog-stock.html.

About Neogen

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Recommended Story: How is net asset value different from market price?

Insider Buying and Selling by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.